Lactylation: From Homeostasis to Pathological Implications and Therapeutic Strategies

Abstract

Lactylation, a recently identified post-translational modification, represents a groundbreaking addition to the epigenetic landscape, revealing its pivotal role in gene regulation and metabolic adaptation. Unlike traditional modifications, lactylation directly links metabolic intermediates, such as lactate, to protein function and cellular behavior. Emerging evidence highlights the critical involvement of lactylation in diverse biological processes, including immune response modulation, cellular differentiation, and tumor progression. However, its regulatory mechanisms, biological implications, and disease associations remain poorly understood. This review systematically explores the enzymatic and nonenzymatic mechanisms underlying protein lactylation, shedding light on the interplay between cellular metabolism and epigenetic control. We comprehensively analyze its biological functions in normal physiology, such as immune homeostasis and tissue repair, and its dysregulation in pathological contexts, including cancer, inflammation, and metabolic disorders. Moreover, we discuss advanced detection technologies and potential therapeutic interventions targeting lactylation pathways. By integrating these insights, this review aims to bridge critical knowledge gaps and propose future directions for research. Highlighting lactylation's multifaceted roles in health and disease, this review provides a timely resource for understanding its clinical implications, particularly as a novel target for precision medicine in metabolic and oncological therapies.

Keywords

biological significance / cancer immunotherapy / pathology / physiology / protein lactylation

References

[1] L. Ye, Y. Jiang, and M. Zhang, “Crosstalk Between Glucose Metabolism, Lactate Production and Immune Response Modulation,” Cytokine & Growth Factor Reviews 68 (2022): 81-92.

[2] D. Zhang, Z. Tang, H. Huang, et al., “Metabolic Regulation of Gene Expression by Histone Lactylation,” Nature 574, no. 7779 (2019): 575-580.

[3] Z. E. Walton, C. H. Patel, R. C. Brooks, et al., “Acid Suspends the Circadian Clock in Hypoxia Through Inhibition of mTOR,” Cell 174, no. 1 (2018): 72-87.e32.

[4] Y. Xie, H. Hu, M. Liu, et al., “The Role and Mechanism of Histone Lactylation in Health and Diseases,” Frontiers in Genetics 13 (2022): 949252.

[5] X. Li, T. Yu, X. Li, X. He, B. Zhang, and Y. Yang, “Role of Novel Protein Acylation Modifications in Immunity and Its Related Diseases,” Immunology 173, no. 1 (2024): 53-75.

[6] B. R. Sabari, D. Zhang, C. D. Allis, and Y. Zhao, “Metabolic Regulation of Gene Expression Through Histone Acylations,” Nature Reviews Molecular Cell Biology 18, no. 2 (2017): 90-101.

[7] D. O. Gaffney, E. Q. Jennings, C. C. Anderson, et al., “Non-Enzymatic Lysine Lactoylation of Glycolytic Enzymes,” Cell Chemical Biology 27, no. 2 (2020): 206-213.e6.

[8] L. Chen, L. Huang, Y. Gu, W. Cang, P. Sun, and Y. Xiang, “Lactate-Lactylation Hands Between Metabolic Reprogramming and Immunosuppression,” International Journal of Molecular Sciences 23, no. 19 (2022): 11943.

[9] S. K. Dai, P. P. Liu, X. Li, L. F. Jiao, Z. Q. Teng, and C. M. Liu, “Dynamic Profiling and Functional Interpretation of Histone Lysine Crotonylation and Lactylation During Neural Development,” Development (Cambridge, England) 149, no. 14 (2022): dev200049.

[10] J. Zhou, L. Zhang, J. Peng, et al., “Astrocytic LRP1 Enables Mitochondria Transfer to Neurons and Mitigates Brain Ischemic Stroke by Suppressing ARF1 Lactylation,” Cell Metabolism 36, no. 9 (2024): 2054-2068.e14.

[11] W. Li, C. Zhou, L. Yu, et al., “Tumor-Derived Lactate Promotes Resistance to Bevacizumab Treatment by Facilitating Autophagy Enhancer Protein RUBCNL Expression Through Histone H3 Lysine 18 Lactylation (H3K18la) in Colorectal Cancer,” Autophagy 20, no. 1 (2024): 114-130.

[12] N. Wang, W. Wang, X. Wang, et al., “Histone Lactylation Boosts Reparative Gene Activation Post-Myocardial Infarction,” Circulation Research 131, no. 11 (2022): 893-908.

[13] A. N. Chen, Y. Luo, Y. H. Yang, et al., “Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects,” Frontiers in Immunology 12 (2021): 688910.

[14] F. M. Joseph and N. L. Young, “Histone Variant-Specific Post-Translational Modifications,” Seminars in Cell & Developmental Biology 135 (2023): 73-84.

[15] D. Bradley, “The Evolution of Post-Translational Modifications,” Current Opinion in Genetics & Development 76 (2022): 101956.

[16] Y. W. Wang, J. C. Zuo, C. Chen, and X. H. Li, “Post-Translational Modifications and Immune Responses in Liver Cancer,” Frontiers in Immunology 14 (2023): 1230465.

[17] L. Zhou, D. S. Ng, J. C. Yam, et al., “Post-Translational Modifications on the Retinoblastoma Protein,” Journal of Biomedical Science 29, no. 1 (2022): 33.

[18] S. Shang, J. Liu, and F. Hua, “Protein Acylation: Mechanisms, Biological Functions and Therapeutic Targets,” Signal Transduction and Targeted Therapy 7, no. 1 (2022): 396.

[19] S. Bhattacharya and B. P. Tu, “Histone Acylation at a Glance,” Journal of Cell Science 137, no. 11 (2024): jcs261250.

[20] Y. Wang and W. Yang, “Proteome-Scale Analysis of Protein S-Acylation Comes of Age,” Journal of Proteome Research 20, no. 1 (2021): 14-26.

[21] M. Kabir, N. Sun, X. Hu, et al., “Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53,” Journal of the American Chemical Society 145, no. 27 (2023): 14932-14944.

[22] S. Trefely, K. Huber, J. Liu, et al., “Quantitative Subcellular Acyl-CoA Analysis Reveals Distinct Nuclear Metabolism and Isoleucine-Dependent Histone Propionylation,” Molecular Cell 82, no. 2 (2022): 447-462.e6.

[23] Y. He, C. C. Zheng, J. Yang, et al., “Lysine Butyrylation of HSP90 Regulated by KAT8 and HDAC11 Confers Chemoresistance,” Cell Discovery 9, no. 1 (2023): 74.

[24] Y. Yang and G. E. Gibson, “Succinylation Links Metabolism to Protein Functions,” Neurochemical Research 44, no. 10 (2019): 2346-2359.

[25] P. Yang, Y. Qin, L. Zeng, et al., “Crotonylation and Disease: Current Progress and Future Perspectives,” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 165 (2023): 115108.

[26] X. Lv, Y. Lv, and X. Dai, “Lactate, Histone Lactylation and Cancer Hallmarks,” Expert Reviews in Molecular Medicine 25 (2023): e7.

[27] H. Fan, F. Yang, Z. Xiao, et al., “Lactylation: Novel Epigenetic Regulatory and Therapeutic Opportunities,” American Journal of Physiology Endocrinology and Metabolism 324, no. 4 (2023): E330-e338.

[28] X. Wang, W. Fan, N. Li, et al., “YY1 Lactylation in Microglia Promotes Angiogenesis Through Transcription Activation-Mediated Upregulation of FGF2,” Genome Biology 24, no. 1 (2023): 87.

[29] K. Yang, M. Fan, X. Wang, et al., “Lactate Promotes Macrophage HMGB1 Lactylation, Acetylation, and Exosomal Release in Polymicrobial Sepsis,” Cell Death and Differentiation 29, no. 1 (2022): 133-146.

[30] X. Gu, A. Zhuang, J. Yu, et al., “Histone Lactylation-Boosted ALKBH3 Potentiates Tumor Progression and Diminished Promyelocytic Leukemia Protein Nuclear Condensates by m1A Demethylation of SP100A,” Nucleic Acids Research 52, no. 5 (2024): 2273-2289.

[31] Y. Huang, G. Luo, K. Peng, et al., “Lactylation Stabilizes TFEB to Elevate Autophagy and Lysosomal Activity,” Journal of Cell Biology 223, no. 11 (2024): e202308099.

[32] E. L. Varner, S. Trefely, D. Bartee, et al., “Quantification of Lactoyl-CoA (lactyl-CoA) by Liquid Chromatography Mass Spectrometry in Mammalian Cells and Tissues,” Open Biology 10, no. 9 (2020): 200187.

[33] Y. Zhou, L. Yang, X. Liu, and H. Wang, “Lactylation May be a Novel Posttranslational Modification in Inflammation in Neonatal Hypoxic-Ischemic Encephalopathy,” Frontiers in Pharmacology 13 (2022): 926802.

[34] K. Matsumoto, M. Iijima, C. Hori, C. Utsunomia, T. Ooi, and S. Taguchi, “In Vitro Analysis of D-Lactyl-CoA-Polymerizing Polyhydroxyalkanoate Synthase in Polylactate and Poly(lactate- co-3-hydroxybutyrate) Syntheses,” Biomacromolecules 19, no. 7 (2018): 2889-2895.

[35] D. Zhang, J. Gao, Z. Zhu, et al., “Lysine L-lactylation is the Dominant Lactylation Isomer Induced by Glycolysis,” Nature Chemical Biology 21, no. 1 (2025): 91-99.

[36] Z. Yang, C. Yan, J. Ma, et al., “Lactylome Analysis Suggests Lactylation-Dependent Mechanisms of Metabolic Adaptation in Hepatocellular Carcinoma,” Nature Metabolism 5, no. 1 (2023): 61-79.

[37] L. Sun, Y. Zhang, B. Yang, et al., “Lactylation of METTL16 Promotes Cuproptosis via m(6)A-modification on FDX1 mRNA in Gastric Cancer,” Nature Communications 14, no. 1 (2023): 6523.

[38] J. Chen, D. Zhao, Y. Wang, et al., “Lactylated Apolipoprotein C-II Induces Immunotherapy Resistance by Promoting Extracellular Lipolysis,” Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 11, no. 38 (2024): e2406333.

[39] H. Hagihara, H. Shoji, H. Otabi, et al., “Protein Lactylation Induced by Neural Excitation,” Cell Reports 37, no. 2 (2021): 109820.

[40] M. N. Trujillo, E. Q. Jennings, E. A. Hoffman, et al., “Lactoylglutathione Promotes Inflammatory Signaling in Macrophages,” Biorxiv: the Preprint Server for Biology (2023), https://doi.org/10.1101/2023.10.10.561739.

[41] M. N. Trujillo, E. Q. Jennings, E. A. Hoffman, et al., “Lactoylglutathione Promotes Inflammatory Signaling in Macrophages Through Histone Lactoylation,” Molecular Metabolism 81 (2024): 101888.

[42] Y. M. Zhao, X. Chen, H. Sun, et al., “Effects of Histone Deacetylase Inhibitors on Transcriptional Regulation of the hsp70 Gene in Drosophila,” Cell Research 16, no. 6 (2006): 566-576.

[43] Y. Xiao, W. Li, H. Yang, et al., “HBO1 is a Versatile Histone Acyltransferase Critical for Promoter Histone Acylations,” Nucleic Acids Research 49, no. 14 (2021): 8037-8059.

[44] Z. Zong, F. Xie, S. Wang, et al., “Alanyl-tRNA Synthetase, AARS1, is a Lactate Sensor and Lactyltransferase That Lactylates p53 and Contributes to Tumorigenesis,” Cell 187, no. 10 (2024): 2375-2392.e33.

[45] J. Ju, H. Zhang, M. Lin, et al., “The Alanyl-tRNA Synthetase AARS1 Moonlights as a Lactyltransferase to Promote YAP Signaling in Gastric Cancer,” Journal of Clinical Investigation 134, no. 10 (2024): e174587.

[46] R. Liu, X. Ren, Y. E. Park, et al., “Nuclear GTPSCS Functions as a Lactyl-CoA Synthetase to Promote Histone Lactylation and Gliomagenesis,” Cell Metabolism 37, no. 2 (2024): 377-394.e9.

[47] G. Millán-Zambrano, A. Burton, A. J. Bannister, and R. Schneider, “Histone Post-Translational Modifications—Cause and Consequence of Genome Function,” Nature Reviews Genetics 23, no. 9 (2022): 563-580.

[48] A. Etier, F. Dumetz, S. Chéreau, and N. Ponts, “Post-Translational Modifications of Histones Are Versatile Regulators of Fungal Development and Secondary Metabolism,” Toxins 14, no. 5 (2022): 317.

[49] T. O. Tolsma and J. C. Hansen, “Post-Translational Modifications and Chromatin Dynamics,” Essays in Biochemistry 63, no. 1 (2019): 89-96.

[50] R. Lv, Q. Bao, and Y. Li, “Regulation of M1‑Type and M2‑Type Macrophage Polarization in RAW264.7 Cells by Galectin‑9,” Molecular Medicine Reports 16, no. 6 (2017): 9111-9119.

[51] Y. Xie, X. Hu, S. Li, et al., “Pharmacological Targeting Macrophage Phenotype via Gut-Kidney Axis Ameliorates Renal Fibrosis in Mice,” Pharmacological Research 178 (2022): 106161.

[52] W. Yang, P. Wang, P. Cao, et al., “Hypoxic In Vitro Culture Reduces Histone Lactylation and Impairs Pre-Implantation Embryonic Development in Mice,” Epigenetics & Chromatin 14, no. 1 (2021): 57.

[53] R. Y. Pan, L. He, J. Zhang, et al., “Positive Feedback Regulation of Microglial Glucose Metabolism by Histone H4 Lysine 12 Lactylation in Alzheimer's Disease,” Cell Metabolism 34, no. 4 (2022): 634-648.e6.

[54] M. C. Dalmasso, D. O. Onyango, A. Naguleswaran, W. J. Sullivan, and S. O. Angel, “Toxoplasma H2A Variants Reveal Novel Insights Into Nucleosome Composition and Functions for This Histone Family,” Journal of Molecular Biology 392, no. 1 (2009): 33-47.

[55] X. Sun, L. He, H. Liu, et al., “The Diapause-Like Colorectal Cancer Cells Induced by SMC4 Attenuation Are Characterized by Low Proliferation and Chemotherapy Insensitivity,” Cell Metabolism 35, no. 9 (2023): 1563-1579.e8.

[56] Q. Xin, H. Wang, Q. Li, et al., “Lactylation: A Passing Fad or the Future of Posttranslational Modification,” Inflammation 45, no. 4 (2022): 1419-1429.

[57] J. Jin, L. Bai, D. Wang, et al., “SIRT3-Dependent Delactylation of Cyclin E2 Prevents Hepatocellular Carcinoma Growth,” EMBO Reports 24, no. 5 (2023): e56052.

[58] X. Sun, C. Bai, H. Li, et al., “PARP1 Modulates METTL3 Promoter Chromatin Accessibility and Associated LPAR5 RNA M(6)A Methylation to Control Cancer Cell Radiosensitivity,” Molecular Therapy: the Journal of the American Society of Gene Therapy 31, no. 9 (2023): 2633-2650.

[59] H. Li, C. Wang, L. Lan, et al., “METTL3 Promotes Oxaliplatin Resistance of Gastric Cancer CD133+ Stem Cells by Promoting PARP1 mRNA Stability,” Cellular and Molecular Life Sciences 79, no. 3 (2022): 135.

[60] Y. Bai, W. Wang, S. Li, et al., “C1QBP Promotes Homologous Recombination by Stabilizing MRE11 and Controlling the Assembly and Activation of MRE11/RAD50/NBS1 Complex,” Molecular Cell 75, no. 6 (2019): 1299-1314.e6.

[61] M. Gao, N. Zhang, and W. Liang, “Systematic Analysis of Lysine Lactylation in the Plant Fungal Pathogen Botrytis cinerea,” Frontiers in Microbiology 11 (2020): 594743.

[62] N. Zhang, N. Jiang, L. Yu, et al., “Protein Lactylation Critically Regulates Energy Metabolism in the Protozoan Parasite Trypanosoma brucei,” Frontiers in Cell and Developmental Biology 9 (2021): 719720.

[63] X. Meng, J. M. Baine, T. Yan, and S. Wang, “Comprehensive Analysis of Lysine Lactylation in Rice (Oryza sativa) Grains,” Journal of Agricultural and Food Chemistry 69, no. 29 (2021): 8287-8297.

[64] J. Xiong, J. He, J. Zhu, et al., “Lactylation-Driven METTL3-Mediated RNA M(6)A Modification Promotes Immunosuppression of Tumor-Infiltrating Myeloid Cells,” Molecular Cell 82, no. 9 (2022): 1660-1677.e10.

[65] P. Jiang, W. Ning, Y. Shi, et al., “FSL-Kla: A Few-Shot Learning-Based Multi-Feature Hybrid System for Lactylation Site Prediction,” Computational and Structural Biotechnology Journal 19 (2021): 4497-4509.

[66] R. Jasso-Chávez, M. E. Torres-Márquez, and R. Moreno-Sánchez, “The Membrane-Bound L- and D-lactate Dehydrogenase Activities in Mitochondria From Euglena gracilis,” Archives of Biochemistry and Biophysics 390, no. 2 (2001): 295-303.

[67] C. Moreno-Yruela, D. Zhang, W. Wei, et al., “Class I Histone Deacetylases (HDAC1-3) Are Histone Lysine Delactylases,” Science Advances 8, no. 3 (2022): eabi6696.

[68] J. Wang, P. Yang, T. Yu, et al., “Lactylation of PKM2 Suppresses Inflammatory Metabolic Adaptation in Pro-Inflammatory Macrophages,” International Journal of Biological Sciences 18, no. 16 (2022): 6210-6225.

[69] H. Chen, Y. Li, H. Li, et al., “NBS1 Lactylation is Required for Efficient DNA Repair and Chemotherapy Resistance,” Nature 631, no. 8021 (2024): 663-669.

[70] X. Li, M. Chen, X. Chen, et al., “TRAP1 Drives Smooth Muscle Cell Senescence and Promotes Atherosclerosis via HDAC3-Primed Histone H4 Lysine 12 Lactylation,” European Heart Journal 45, no. 39 (2024): 4219-4235.

[71] L. Li, K. Chen, T. Wang, et al., “Glis1 Facilitates Induction of Pluripotency via an Epigenome-Metabolome-Epigenome Signalling Cascade,” Nature Metabolism 2, no. 9 (2020): 882-892.

[72] F. Merkuri, M. Rothstein, and M. Simoes-Costa, “Histone Lactylation Couples Cellular Metabolism With Developmental Gene Regulatory Networks,” Nature Communications 15, no. 1 (2024): 90.

[73] L. Pan, F. Feng, J. Wu, et al., “Demethylzeylasteral Targets Lactate by Inhibiting Histone Lactylation to Suppress the Tumorigenicity of Liver Cancer Stem Cells,” Pharmacological Research 181 (2022): 106270.

[74] T. Zhou, X. Cheng, Y. He, et al., “Function and Mechanism of Histone β-hydroxybutyrylation in Health and Disease,” Frontiers in Immunology 13 (2022): 981285.

[75] L. Baďurová, K. Polčicová, B. Omasta, I. Ovečková, E. Kocianová, and J. Tomášková, “2-Deoxy-D-glucose Inhibits Lymphocytic Choriomeningitis Virus Propagation by Targeting Glycoprotein N-glycosylation,” Virology Journal 20, no. 1 (2023): 108.

[76] X. Lin, Y. Lei, M. Pan, et al., “Augmentation of Scleral Glycolysis Promotes Myopia Through Histone Lactylation,” Cell Metabolism 36, no. 3 (2024): 511-525.e7.

[77] J. Chen, M. Zhang, Y. Liu, et al., “Histone Lactylation Driven by mROS-Mediated Glycolytic Shift Promotes Hypoxic Pulmonary Hypertension,” Journal of Molecular Cell Biology 14, no. 12 (2023): mjac073.

[78] A. Le, C. R. Cooper, A. M. Gouw, et al., “Inhibition of Lactate Dehydrogenase A Induces Oxidative Stress and Inhibits Tumor Progression,” Proceedings of the National Academy of Sciences of the United States of America 107, no. 5 (2010): 2037-2042.

[79] R. A. Irizarry-Caro, M. M. McDaniel, G. R. Overcast, V. G. Jain, T. D. Troutman, and C. Pasare, “TLR Signaling Adapter BCAP Regulates Inflammatory to Reparatory Macrophage Transition by Promoting Histone Lactylation,” Proceedings of the National Academy of Sciences of the United States of America 117, no. 48 (2020): 30628-30638.

[80] M. A. Felmlee, R. S. Jones, V. Rodriguez-Cruz, K. E. Follman, and M. E. Morris, “Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease,” Pharmacological Reviews 72, no. 2 (2020): 466-485.

[81] A. P. Halestrap and N. T. Price, “The Proton-Linked Monocarboxylate Transporter (MCT) Family: Structure, Function and Regulation,” Biochemical Journal 343, no. Pt 2 (1999): 281-299.

[82] B. Alobaidi, S. M. Hashimi, A. I. Alqosaibi, N. AlQurashi, and S. Alhazmi, “Targeting the Monocarboxylate Transporter MCT2 and Lactate Dehydrogenase A LDHA in Cancer Cells With FX-11 and AR-C155858 Inhibitors,” European Review for Medical and Pharmacological Sciences 27, no. 14 (2023): 6605-6617.

[83] P. Li, J. Ge, and H. Li, “Lysine Acetyltransferases and Lysine Deacetylases as Targets for Cardiovascular Disease,” Nature Reviews Cardiology 17, no. 2 (2020): 96-115.

[84] J. Wang, S. Feng, Q. Zhang, et al., “Roles of Histone Acetyltransferases and Deacetylases in the Retinal Development and Diseases,” Molecular Neurobiology 60, no. 4 (2023): 2330-2354.

[85] W. J. Sun, X. Zhou, J. H. Zheng, et al., “Histone Acetyltransferases and Deacetylases: Molecular and Clinical Implications to Gastrointestinal Carcinogenesis,” Acta Biochimica Et Biophysica Sinica 44, no. 1 (2012): 80-91.

[86] S. P. Thomas and J. M. Denu, “Short-Chain Fatty Acids Activate Acetyltransferase p300,” eLife 10 (2021): e72171.

[87] M. C. Garrett, R. Albano, T. Carnwath, et al., “HDAC1 and HDAC6 Are Essential for Driving Growth in IDH1 Mutant Glioma,” Scientific Reports 13, no. 1 (2023): 12433.

[88] Y. Itoh, T. Suzuki, and N. Miyata, “Isoform-Selective Histone Deacetylase Inhibitors,” Current Pharmaceutical Design 14, no. 6 (2008): 529-544.

[89] L. Li, K. Chen, Y. Wu, G. Xiang, and X. Liu, “Epigenome-Metabolome-Epigenome Signaling Cascade in Cell Biological Processes,” Journal of Genetics and Genomics = Yi Chuan Xue Bao 49, no. 4 (2022): 279-286.

[90] J. Yang, L. Luo, C. Zhao, et al., “A Positive Feedback Loop Between Inactive VHL-Triggered Histone Lactylation and PDGFRβ Signaling Drives Clear Cell Renal Cell Carcinoma Progression,” International Journal of Biological Sciences 18, no. 8 (2022): 3470-3483.

[91] I. Samaržija, “Post-Translational Modifications That Drive Prostate Cancer Progression,” Biomolecules 11, no. 2 (2021): 247.

[92] C. Sharma, A. Hamza, E. Boyle, D. Donu, and Y. Cen, “Post-Translational Modifications and Diabetes,” Biomolecules 14, no. 3 (2024): 310.

[93] J. Yu, P. Chai, M. Xie, et al., “Histone Lactylation Drives Oncogenesis by Facilitating M(6)A Reader Protein YTHDF2 Expression in Ocular Melanoma,” Genome Biology 22, no. 1 (2021): 85.

[94] S. Wang, L. Ma, Z. Wang, et al., “Lactate Dehydrogenase-A (LDH-A) Preserves Cancer Stemness and Recruitment of Tumor-Associated Macrophages to Promote Breast Cancer Progression,” Frontiers in Oncology 11 (2021): 654452.

[95] Y. Ding, X. Yuan, Y. Zou, et al., “OCT4, SOX2 and NANOG Co-Regulate Glycolysis and Participate in Somatic Induced Reprogramming,” Cytotechnology 74, no. 3 (2022): 371-383.

[96] X. Liu, Y. Zhang, W. Li, and X. Zhou, “Lactylation, an Emerging Hallmark of Metabolic Reprogramming: Current Progress and Open Challenges,” Frontiers in Cell and Developmental Biology 10 (2022): 972020.

[97] Y. Chen, J. Wu, L. Zhai, et al., “Metabolic Regulation of Homologous Recombination Repair by MRE11 Lactylation,” Cell 187, no. 2 (2024): 294-311.e21.

[98] T. Wang, Z. Ye, Z. Li, et al., “Lactate-Induced Protein Lactylation: A Bridge Between Epigenetics and Metabolic Reprogramming in Cancer,” Cell Proliferation 56, no. 10 (2023): e13478.

[99] H. Gong, H. Zhong, L. Cheng, L. P. Li, and D. K. Zhang, “Post-Translational Protein Lactylation Modification in Health and Diseases: A Double-Edged Sword,” Journal of Translational Medicine 22, no. 1 (2024): 41.

[100] J. Wang, Z. Wang, Q. Wang, X. Li, and Y. Guo, “Ubiquitous Protein Lactylation in Health and Diseases,” Cellular & Molecular Biology Letters 29, no. 1 (2024): 23.

[101] X. Chu, C. Di, P. Chang, et al., “Lactylated Histone H3K18 as a Potential Biomarker for the Diagnosis and Predicting the Severity of Septic Shock,” Frontiers in Immunology 12 (2021): 786666.

[102] Q. Tang, C. Xing, M. Li, Q. Jia, C. Bo, and Z. Zhang, “Pirfenidone Ameliorates Pulmonary Inflammation and Fibrosis in a Rat Silicosis Model by Inhibiting Macrophage Polarization and JAK2/STAT3 Signaling Pathways,” Ecotoxicology and Environmental Safety 244 (2022): 114066.

[103] A. Brand, K. Singer, G. E. Koehl, et al., “LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells,” Cell Metabolism 24, no. 5 (2016): 657-671.

[104] C. Chen, Z. Wang, Y. Ding, and Y. Qin, “Tumor Microenvironment-Mediated Immune Evasion in Hepatocellular Carcinoma,” Frontiers in Immunology 14 (2023): 1133308.

[105] J. Zhao, A. X. Chen, R. D. Gartrell, et al., “Immune and Genomic Correlates of Response to Anti-PD-1 Immunotherapy in Glioblastoma,” Nature Medicine 25, no. 3 (2019): 462-469.

[106] J. Gu, J. Zhou, Q. Chen, et al., “Tumor Metabolite Lactate Promotes Tumorigenesis by Modulating MOESIN Lactylation and Enhancing TGF-β Signaling in Regulatory T Cells,” Cell Reports 39, no. 12 (2022): 110986.

[107] Z. H. Wang, P. Zhang, W. B. Peng, et al., “Altered Phenotypic and Metabolic Characteristics of FOXP3(+)CD3(+)CD56(+) Natural Killer T (NKT)-Like Cells in Human Malignant Pleural Effusion,” Oncoimmunology 12, no. 1 (2023): 2160558.

[108] Y. Zhang, H. Jiang, M. Dong, et al., “Macrophage MCT4 Inhibition Activates Reparative Genes and Protects From Atherosclerosis by Histone H3 Lysine 18 Lactylation,” Cell Reports 43, no. 5 (2024): 114180.

[109] L. Wang, S. Li, H. Luo, Q. Lu, and S. Yu, “PCSK9 Promotes the Progression and Metastasis of Colon Cancer Cells Through Regulation of EMT and PI3K/AKT Signaling in Tumor Cells and Phenotypic Polarization of Macrophages,” Journal of Experimental & Clinical Cancer Research 41, no. 1 (2022): 303.

[110] K. Chaudagar, H. M. Hieromnimon, R. Khurana, et al., “Reversal of Lactate and PD-1-Mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-Deficient Prostate Cancer,” Clinical Cancer Research 29, no. 10 (2023): 1952-1968.

[111] A. De Leo, A. Ugolini, X. Yu, et al., “Glucose-Driven Histone Lactylation Promotes the Immunosuppressive Activity of Monocyte-Derived Macrophages in Glioblastoma,” Immunity 57, no. 5 (2024): 1105-1123.e8.

[112] X. M. Li, Y. Yang, F. Q. Jiang, et al., “Histone Lactylation Inhibits RARγ Expression in Macrophages to Promote Colorectal Tumorigenesis Through Activation of TRAF6-IL-6-STAT3 Signaling,” Cell Reports 43, no. 2 (2024): 113688.

[113] X. Fang, P. Zhao, S. Gao, et al., “Lactate Induces Tumor-Associated Macrophage Polarization Independent of Mitochondrial Pyruvate Carrier-Mediated Metabolism,” International Journal of Biological Macromolecules 237 (2023): 123810.

[114] J. Cai, L. Song, F. Zhang, et al., “Targeting SRSF10 Might Inhibit M2 Macrophage Polarization and Potentiate Anti-PD-1 Therapy in Hepatocellular Carcinoma,” Cancer Communications (London, England) 44, no. 11 (2024): 1231-1260.

[115] X. Wu, T. Mi, L. Jin, et al., “Dual Roles of HK3 in Regulating the Network Between Tumor Cells and Tumor-Associated Macrophages in Neuroblastoma,” Cancer Immunology, Immunotherapy 73, no. 7 (2024): 122.

[116] J. M. Hsu, C. W. Li, Y. J. Lai, and H. MC, “Posttranslational Modifications of PD-L1 and Their Applications in Cancer Therapy,” Cancer Research 78, no. 22 (2018): 6349-6353.

[117] Q. Zhang, K. Zhao, Q. Shen, et al., “Tet2 is Required to Resolve Inflammation by Recruiting Hdac2 to Specifically Repress IL-6,” Nature 525, no. 7569 (2015): 389-393.

[118] N. Lv, S. Jin, Z. Liang, et al., “PP2Cδ Controls the Differentiation and Function of Dendritic Cells Through Regulating the NSD2/mTORC2/ACLY Pathway,” Frontiers in Immunology 12 (2021): 751409.

[119] R. Wang, C. Li, Z. Cheng, et al., “H3K9 Lactylation in Malignant Cells Facilitates CD8(+) T Cell Dysfunction and Poor Immunotherapy Response,” Cell Reports 43, no. 9 (2024): 114686.

[120] D. Raychaudhuri, P. Singh, B. Chakraborty, et al., “Histone Lactylation Drives CD8(+) T Cell Metabolism and Function,” Nature Immunology 25, no. 11 (2024): 2140-2151.

[121] C. Zhang, L. Zhou, M. Zhang, et al., “H3K18 Lactylation Potentiates Immune Escape of Non-Small Cell Lung Cancer,” Cancer Research 84, no. 21 (2024): 3589-3601.

[122] Z. W. Huang, X. N. Zhang, L. Zhang, et al., “STAT5 Promotes PD-L1 Expression by Facilitating Histone Lactylation to Drive Immunosuppression in Acute Myeloid Leukemia,” Signal Transduction and Targeted Therapy 8, no. 1 (2023): 391.

[123] H. Tong, Z. Jiang, L. Song, et al., “Dual Impacts of Serine/Glycine-Free Diet in Enhancing Antitumor Immunity and Promoting Evasion via PD-L1 Lactylation,” Cell Metabolism 36, no. 12 (2024): 2493-2510.e9.

[124] M. Hu, B. Alashkar Alhamwe, B. Santner-Nanan, et al., “Short-Chain Fatty Acids Augment Differentiation and Function of Human Induced Regulatory T Cells,” International Journal of Molecular Sciences 23, no. 10 (2022): 5740.

[125] T. MaruYama, S. Kobayashi, H. Nakatsukasa, et al., “The Curcumin Analog GO-Y030 Controls the Generation and Stability of Regulatory T Cells,” Frontiers in Immunology 12 (2021): 687669.

[126] J. Castillo, E. Wu, C. Lowe, et al., “CBP/p300 Drives the Differentiation of Regulatory T Cells Through Transcriptional and Non-Transcriptional Mechanisms,” Cancer Research 79, no. 15 (2019): 3916-3927.

[127] Y. Kashiwakura, H. Kojima, Y. Kanno, M. Hashiguchi, and T. Kobata, “Heparin Affects the Induction of Regulatory T Cells Independent of Anti-Coagulant Activity and Suppresses Allogeneic Immune Responses,” Clinical and Experimental Immunology 202, no. 1 (2020): 119-135.

[128] J. Xiong, B. W. Cui, N. Wang, et al., “Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma,” Cancer Cell 37, no. 3 (2020): 403-419.e6.

[129] J. Zhou, S. H. Toh, T. K. Tan, et al., “Super-Enhancer-Driven TOX2 Mediates Oncogenesis in Natural Killer/T Cell Lymphoma,” Molecular Cancer 22, no. 1 (2023): 69.

[130] J. O'Keeffe, M. Podbielska, and E. L. Hogan, “Invariant Natural Killer T Cells and Their Ligands: Focus on Multiple Sclerosis,” Immunology 145, no. 4 (2015): 468-475.

[131] F. Li, W. Si, L. Xia, et al., “Positive Feedback Regulation Between Glycolysis and Histone Lactylation Drives Oncogenesis in Pancreatic Ductal Adenocarcinoma,” Molecular Cancer 23, no. 1 (2024): 90.

[132] Y. Wang, H. Li, S. Jiang, et al., “The Glycolytic Enzyme PFKFB3 Drives Kidney Fibrosis Through Promoting Histone Lactylation-Mediated NF-κB Family Activation,” Kidney International 106, no. 2 (2024): 226-240.

[133] Q. Yue, Z. Wang, Y. Shen, et al., “Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2-Mediated MLH1 Intron Retention,” Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 11, no. 19 (2024): e2309290.

[134] B. Yu, F. Luo, B. Sun, et al., “KAT6A Acetylation of SMAD3 Regulates Myeloid-Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple-Negative Breast Cancer,” Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 8, no. 20 (2021): e2100014.

[135] G. Liu, Q. Wang, L. Deng, et al., “Hepatic RACK1 Deficiency Protects Against Fulminant hepatitis Through Myeloid-Derived Suppressor Cells,” Theranostics 12, no. 5 (2022): 2248-2265.

[136] W. Wang, Y. Chen, R. Du, et al., “C/EBPβ Enhances Immunosuppression Activity of Myeloid-Derived Suppressor Cells by a P300-Mediated Acetylation Modification,” Inflammation Research 71, no. 12 (2022): 1547-1557.

[137] G. S. Lei, C. Zhang, and C. H. Lee, “Myeloid-Derived Suppressor Cells Impair Alveolar Macrophages Through PD-1 Receptor Ligation During Pneumocystis Pneumonia,” Infection and Immunity 83, no. 2 (2015): 572-582.

[138] H. Yang, X. Zou, S. Yang, A. Zhang, N. Li, and Z. Ma, “Identification of Lactylation Related Model to Predict Prognostic, Tumor Infiltrating Immunocytes and Response of Immunotherapy in Gastric Cancer,” Frontiers in Immunology 14 (2023): 1149989.

[139] D. Cai, X. Yuan, D. Q. Cai, et al., “Integrative Analysis of Lactylation-Related Genes and Establishment of a Novel Prognostic Signature for Hepatocellular Carcinoma,” Journal of Cancer Research and Clinical Oncology 149, no. 13 (2023): 11517-11530.

[140] X. Xu, J. Wu, Y. Jin, K. Huang, Y. Zhang, and Z. Liang, “Both Saccharomyces boulardii and Its Postbiotics Alleviate Dextran Sulfate Sodium-Induced Colitis in Mice, Association With Modulating Inflammation and Intestinal Microbiota,” Nutrients 15, no. 6 (2023): 1484.

[141] P. Scheltens, K. Blennow, M. M. Breteler, et al., “Alzheimer's Disease,” Lancet (London, England) 388, no. 10043 (2016): 505-517.

[142] J. L. Cummings, G. Tong, and C. Ballard, “Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options,” Journal of Alzheimer's Disease 67, no. 3 (2019): 779-794.

[143] F. Angelucci, K. Cechova, J. Amlerova, and J. Hort, “Antibiotics, Gut Microbiota, and Alzheimer's Disease,” Journal of Neuroinflammation 16, no. 1 (2019): 108.

[144] L. Wei, X. Yang, J. Wang, et al., “H3K18 Lactylation of Senescent Microglia Potentiates Brain Aging and Alzheimer's Disease Through the NFκB Signaling Pathway,” Journal of Neuroinflammation 20, no. 1 (2023): 208.

[145] S. Lopes-Paciencia, E. Saint-Germain, M. C. Rowell, A. F. Ruiz, P. Kalegari, and G. Ferbeyre, “The Senescence-Associated Secretory Phenotype and Its Regulation,” Cytokine 117 (2019): 15-22.

[146] Y. Zhang and X. Zhang, “Virus-Induced Histone Lactylation Promotes Virus Infection in Crustacean,” Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 11, no. 30 (2024): e2401017.

[147] X. Liu, Y. Zhou, and H. Wang, “The Role of Lactate-Induced Protein Lactylation in Gliomas: Implications for Preclinical Research and the Development of New Treatments,” Frontiers in Pharmacology 15 (2024): 1383274.

[148] X. Wang, Q. Liu, H. T. Yu, et al., “A Positive Feedback Inhibition of Isocitrate Dehydrogenase 3β on Paired-Box Gene 6 Promotes Alzheimer-Like Pathology,” Signal Transduction and Targeted Therapy 9, no. 1 (2024): 105.

[149] S. Xu, P. Huang, J. Yang, H. Du, H. Wan, and Y. He, “Calycosin Alleviates Cerebral Ischemia/Reperfusion Injury by Repressing Autophagy via STAT3/FOXO3a Signaling Pathway,” Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 115 (2023): 154845.

[150] L. Yu, Y. Zhang, Q. Chen, et al., “Formononetin Protects Against Inflammation Associated With Cerebral Ischemia-Reperfusion Injury in Rats by Targeting the JAK2/STAT3 Signaling Pathway,” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 149 (2022): 112836.

[151] R. Li, H. Jia, M. Si, et al., “Loureirin B Protects Against Cerebral Ischemia/Reperfusion Injury Through Modulating M1/M2 Microglial Polarization via STAT6 /NF-kappaB Signaling Pathway,” European Journal of Pharmacology 953 (2023): 175860.

[152] Y. Yao, R. Bade, G. Li, et al., “Global-Scale Profiling of Differential Expressed Lysine-Lactylated Proteins in the Cerebral Endothelium of Cerebral Ischemia-Reperfusion Injury Rats,” Cellular and Molecular Neurobiology 43, no. 5 (2023): 1989-2004.

[153] Y. Liu, H. Zhang, Y. Liu, et al., “Hypoxia-Induced GPCPD1 Depalmitoylation Triggers Mitophagy via Regulating PRKN-Mediated Ubiquitination of VDAC1,” Autophagy 19, no. 9 (2023): 2443-2463.

[154] L. Yang, Y. He, Q. Kong, et al., “Isolation, Nucleotide Identification and Tissue Expression of Three Novel Ovine Genes-SLC25A4, SLC25A5 and SLC25A6,” Molecular Biology Reports 37, no. 6 (2010): 2743-2748.

[155] J. Li, S. Shen, and H. Shen, “Heat-Shock Protein A12A Attenuates Oxygen-Glucose Deprivation/Reoxygenation-Induced Human Brain Microvascular Endothelial Cell Dysfunction via PGC-1α/SIRT3 Pathway,” Drug Development Research 85, no. 1 (2024): e22130.

[156] S. Du, X. Zhang, Y. Jia, et al., “Hepatocyte HSPA12A Inhibits Macrophage Chemotaxis and Activation to Attenuate Liver Ischemia/Reperfusion Injury via Suppressing Glycolysis-Mediated HMGB1 Lactylation and Secretion of Hepatocytes,” Theranostics 13, no. 11 (2023): 3856-3871.

[157] H. L. Li, X. Wu, A. Xu, and R. L. Hoo, “A-FABP in Metabolic Diseases and the Therapeutic Implications: An Update,” International Journal of Molecular Sciences 22, no. 17 (2021): 9386.

[158] J. Chen, Q. Feng, Y. Qiao, et al., “ACSF2 and Lysine Lactylation Contribute to Renal Tubule Injury in Diabetes,” Diabetologia 67, no. 7 (2024): 1429-1443.

[159] S. Wang, N. Moustaid-Moussa, L. Chen, et al., “Novel Insights of Dietary Polyphenols and Obesity,” Journal of Nutritional Biochemistry 25, no. 1 (2014): 1-18.

[160] R. Gao, Y. Li, Z. Xu, et al., “Mitochondrial Pyruvate Carrier 1 Regulates Fatty Acid Synthase Lactylation and Mediates Treatment of Nonalcoholic Fatty Liver Disease,” Hepatology (Baltimore, Md) 78, no. 6 (2023): 1800-1815.

[161] X. Cheng, K. Wang, Y. Zhao, and K. Wang, “Research Progress on Post-Translational Modification of Proteins and Cardiovascular Diseases,” Cell Death Discovery 9, no. 1 (2023): 275.

[162] M. Fan, K. Yang, X. Wang, et al., “Lactate Promotes Endothelial-to-Mesenchymal Transition via Snail1 Lactylation After Myocardial Infarction,” Science Advances 9, no. 5 (2023): eadc9465.

[163] S. Han, X. Bao, Y. Zou, et al., “d-Lactate Modulates M2 Tumor-Associated Macrophages and Remodels Immunosuppressive Tumor Microenvironment for Hepatocellular Carcinoma,” Science Advances 9, no. 29 (2023): eadg2697.

[164] N. Zhang, Y. Zhang, J. Xu, et al., “α-Myosin Heavy Chain Lactylation Maintains Sarcomeric Structure and Function and Alleviates the Development of Heart Failure,” Cell Research 33, no. 9 (2023): 679-698.

[165] W. Ma, K. Jia, H. Cheng, et al., “Orphan Nuclear Receptor NR4A3 Promotes Vascular Calcification via Histone Lactylation,” Circulation Research 134, no. 11 (2024): 1427-1447.

[166] L. F. Barros, I. Ruminot, A. San Martín, R. Lerchundi, I. Fernández-Moncada, and F. Baeza-Lehnert, “Aerobic Glycolysis in the Brain: Warburg and Crabtree Contra Pasteur,” Neurochemical Research 46, no. 1 (2021): 15-22.

[167] L. Sun, H. Zhang, and P. Gao, “Metabolic Reprogramming and Epigenetic Modifications on the Path to Cancer,” Protein & Cell 13, no. 12 (2022): 877-919.

[168] B. Xie, J. Lin, X. Chen, et al., “CircXRN2 Suppresses Tumor Progression Driven by Histone Lactylation Through Activating the Hippo Pathway in Human Bladder Cancer,” Molecular Cancer 22, no. 1 (2023): 151.

[169] Q. Meng, Y. Zhang, H. Sun, et al., “Human Papillomavirus-16 E6 Activates the Pentose Phosphate Pathway to Promote Cervical Cancer Cell Proliferation by Inhibiting G6PD Lactylation,” Redox Biology 71 (2024): 103108.

[170] Q. Meng, H. Sun, Y. Zhang, et al., “Lactylation Stabilizes DCBLD1 Activating the Pentose Phosphate Pathway to Promote Cervical Cancer Progression,” Journal of Experimental & Clinical Cancer Research 43, no. 1 (2024): 36.

[171] J. Zhou, W. Xu, Y. Wu, et al., “GPR37 Promotes Colorectal Cancer Liver Metastases by Enhancing the Glycolysis and Histone Lactylation via Hippo Pathway,” Oncogene 42, no. 45 (2023): 3319-3330.

[172] B. Xie, M. Zhang, J. Li, et al., “KAT8-Catalyzed Lactylation Promotes eEF1A2-Mediated Protein Synthesis and Colorectal Carcinogenesis,” Proceedings of the National Academy of Sciences of the United States of America 121, no. 8 (2024): e2314128121.

[173] S. Wei, J. Zhang, R. Zhao, et al., “Histone Lactylation Promotes Malignant Progression by Facilitating USP39 Expression to Target PI3K/AKT/HIF-1α Signal Pathway in Endometrial Carcinoma,” Cell Death Discovery 10, no. 1 (2024): 121.

[174] T. Sun, B. Liu, Y. Li, et al., “Oxamate Enhances the Efficacy of CAR-T Therapy Against Glioblastoma via Suppressing Ectonucleotidases and CCR8 Lactylation,” Journal of Experimental & Clinical Cancer Research 42, no. 1 (2023): 253.

[175] W. Wang, H. Wang, Q. Wang, X. Yu, and L. Ouyang, “Lactate-Induced Protein Lactylation in Cancer: Functions, Biomarkers and Immunotherapy Strategies,” Frontiers in Immunology 15 (2024): 1513047.

[176] H. Huang, S. Wang, H. Xia, et al., “Lactate Enhances NMNAT1 Lactylation to Sustain Nuclear NAD(+) Salvage Pathway and Promote Survival of Pancreatic Adenocarcinoma Cells Under Glucose-Deprived Conditions,” Cancer Letters 588 (2024): 216806.

[177] Y. Yu, X. Huang, C. Liang, and P. Zhang, “Evodiamine Impairs HIF1A Histone Lactylation to Inhibit Sema3A-Mediated Angiogenesis and PD-L1 by Inducing Ferroptosis in Prostate Cancer,” European Journal of Pharmacology 957 (2023): 176007.

[178] X. W. Zhang, L. Li, M. Liao, et al., “Thermal Proteome Profiling Strategy Identifies CNPY3 as a Cellular Target of Gambogic Acid for Inducing Prostate Cancer Pyroptosis,” Journal of Medicinal Chemistry 67, no. 12 (2024): 10005-10011.

[179] S. Jonna and D. S. Subramaniam, “Molecular Diagnostics and Targeted Therapies in Non-Small Cell Lung Cancer (NSCLC): An Update,” Discovery Medicine 27, no. 148 (2019): 167-170.

[180] J. Jiang, D. Huang, Y. Jiang, et al., “Lactate Modulates Cellular Metabolism Through Histone Lactylation-Mediated Gene Expression in Non-Small Cell Lung Cancer,” Frontiers in Oncology 11 (2021): 647559.

[181] P. Zheng, Z. Mao, M. Luo, et al., “Comprehensive Bioinformatics Analysis of the Solute Carrier Family and Preliminary Exploration of SLC25A29 in Lung Adenocarcinoma,” Cancer Cell International 23, no. 1 (2023): 222.

[182] F. Yan, Y. Teng, X. Li, et al., “Hypoxia Promotes Non-Small Cell Lung Cancer Cell Stemness, Migration, and Invasion via Promoting Glycolysis by Lactylation of SOX9,” Cancer Biology & Therapy 25, no. 1 (2024): 2304161.

[183] Y. Sun, W. Gong, and S. Zhang, “METTL3 Promotes Colorectal Cancer Progression Through Activating JAK1/STAT3 Signaling Pathway,” Cell Death & Disease 14, no. 11 (2023): 765.

[184] H. Ma, J. Wang, X. Zhao, et al., “Periostin Promotes Colorectal Tumorigenesis Through Integrin-FAK-Src Pathway-Mediated YAP/TAZ Activation,” Cell Reports 30, no. 3 (2020): 793-806.e6.

[185] Y. D. Chu, L. C. Cheng, S. N. Lim, M. W. Lai, C. T. Yeh, and W. R. Lin, “Aldolase B-Driven Lactagenesis and CEACAM6 Activation Promote Cell Renewal and Chemoresistance in Colorectal Cancer Through the Warburg Effect,” Cell Death & Disease 14, no. 10 (2023): 660.

[186] X. C. Wang, G. Q. Zhao, J. Lin, C. Li, N. Jiang, and J. Zhang, “Effects of Retinoic Acid Receptor-γ on the Aspergillus fumigatus Induced Innate Immunity Response in Human Corneal Epithelial Cells,” International Journal of Ophthalmology 9, no. 12 (2016): 1713-1718.

[187] Z. Bian, J. Zhang, M. Li, et al., “Long Non-Coding RNA LINC00152 Promotes Cell Proliferation, Metastasis, and Confers 5-FU Resistance in Colorectal Cancer by Inhibiting miR-139-5p,” Oncogenesis 6, no. 11 (2017): 395.

[188] M. R. Pandkar, S. Sinha, A. Samaiya, and S. Shukla, “Oncometabolite Lactate Enhances Breast Cancer Progression by Orchestrating Histone Lactylation-Dependent c-Myc Expression,” Translational Oncology 37 (2023): 101758.

[189] Y. Lu, T. Bao, J. Mo, J. Ni, and W. Chen, “Research Advances in Bioactive Components and Health Benefits of Jujube (Ziziphus jujuba Mill.) Fruit,” Journal of Zhejiang University Science B 22, no. 6 (2021): 431-449.

[190] A. Tasdogan, B. Faubert, V. Ramesh, et al., “Metabolic Heterogeneity Confers Differences in Melanoma Metastatic Potential,” Nature 577, no. 7788 (2020): 115-120.

[191] Y. Luo, Z. Yang, Y. Yu, and P. Zhang, “HIF1α Lactylation Enhances KIAA1199 Transcription to Promote Angiogenesis and Vasculogenic Mimicry in Prostate Cancer,” International Journal of Biological Macromolecules 222, no. Pt B (2022): 2225-2243.

[192] L. A. Mata, J. A. Retamero, R. T. Gupta, R. García Figueras, and A. Luna, “Artificial Intelligence-Assisted Prostate Cancer Diagnosis: Radiologic-Pathologic Correlation,” Radiographics 41, no. 6 (2021): 1676-1697.

[193] M. Chen, K. Cen, Y. Song, et al., “NUSAP1-LDHA-Glycolysis-Lactate Feedforward Loop Promotes Warburg Effect and Metastasis in Pancreatic Ductal Adenocarcinoma,” Cancer Letters 567 (2023): 216285.

[194] J. R. Doherty and J. L. Cleveland, “Targeting Lactate Metabolism for Cancer Therapeutics,” Journal of Clinical Investigation 123, no. 9 (2013): 3685-3692.

[195] H. Li, C. Liu, R. Li, et al., “AARS1 and AARS2 Sense L-lactate to Regulate cGAS as Global Lysine Lactyltransferases,” Nature 634, no. 8036 (2024): 1229-1237.

[196] Z. H. Wang, W. B. Peng, P. Zhang, X. P. Yang, and Q. Zhou, “Lactate in the Tumour Microenvironment: From Immune Modulation to Therapy,” EBioMedicine 73 (2021): 103627.

[197] H. E. Bridgewater, E. M. Bolitho, I. Romero-Canelón, P. J. Sadler, and J. P. C. Coverdale, “Targeting Cancer Lactate Metabolism With Synergistic Combinations of Synthetic Catalysts and Monocarboxylate Transporter,” Journal of Biological Inorganic 28, no. 3 (2023): 345-353.

[198] W. Wei, T. Li, J. Chen, et al., “SIRT3/6: An Amazing Challenge and Opportunity in the Fight Against Fibrosis and Aging,” Cellular and Molecular Life Sciences 81, no. 1 (2024): 69.

[199] M. J. Ramaiah, A. D. Tangutur, and R. R. Manyam, “Epigenetic Modulation and Understanding of HDAC Inhibitors in Cancer Therapy,” Life Sciences 277 (2021): 119504.

[200] L. Y. Cai, S. J. Chen, S. H. Xiao, et al., “Targeting p300/CBP Attenuates Hepatocellular Carcinoma Progression Through Epigenetic Regulation of Metabolism,” Cancer Research 81, no. 4 (2021): 860-872.

[201] A. Naimi, R. N. Mohammed, A. Raji, et al., “Tumor Immunotherapies by Immune Checkpoint Inhibitors (ICIs); the Pros and Cons,” Cell Communication and Signaling 20, no. 1 (2022): 44.

[202] S. J. Wang, S. K. Dougan, and M. Dougan, “Immune Mechanisms of Toxicity From Checkpoint Inhibitors,” Trends in Cancer 9, no. 7 (2023): 543-553.

[203] S. Bagchi, R. Yuan, and E. G. Engleman, “Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance,” Annual Review of Pathology 16 (2021): 223-249.

[204] M. R. Niewisch, Z. Kuçi, H. Wolburg, et al., “Influence of Dichloroacetate (DCA) on Lactate Production and Oxygen Consumption in Neuroblastoma Cells: Is DCA a Suitable Drug for Neuroblastoma Therapy?,” Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology 29, no. 3-4 (2012): 373-380.

[205] C. Y. Chung, K. Singh, P. Sheshadri, et al., “Inhibition of the PI3K-AKT-MTORC1 Axis Reduces the Burden of the M.3243A>G mtDNA Mutation by Promoting Mitophagy and Improving Mitochondrial Function,” Autophagy 21, no. 4 (2024): 881-896.

[206] J. Xia, Z. Qiao, X. Hao, and Y. Zhang, “LDHA-Induced Histone Lactylation Mediates the Development of Osteoarthritis Through Regulating the Transcription Activity of TPI1 Gene,” Autoimmunity 57, no. 1 (2024): 2384889.

[207] D. Wu, C. B. Spencer, L. Ortoga, H. Zhang, and C. Miao, “Histone Lactylation-Regulated METTL3 Promotes Ferroptosis via m6A-Modification on ACSL4 in Sepsis-Associated Lung Injury,” Redox Biology 74 (2024): 103194.

[208] H. Cai, J. Li, Y. Zhang, et al., “LDHA Promotes Oral Squamous Cell Carcinoma Progression Through Facilitating Glycolysis and Epithelial-Mesenchymal Transition,” Frontiers in Oncology 9 (2019): 1446.

[209] W. Blaszczak, H. Williams, and P. Swietach, “Autoregulation of H(+)/Lactate Efflux Prevents Monocarboxylate Transport (MCT) Inhibitors From Reducing Glycolytic Lactic Acid Production,” British Journal of Cancer 127, no. 7 (2022): 1365-1377.

[210] M. J. Forteza, M. Berg, A. Edsfeldt, et al., “Pyruvate Dehydrogenase Kinase Regulates Vascular Inflammation in Atherosclerosis and Increases Cardiovascular Risk,” Cardiovascular Research 119, no. 7 (2023): 1524-1536.

[211] A. Hadjihambi, C. Konstantinou, J. Klohs, et al., “Partial MCT1 Invalidation Protects Against Diet-Induced Non-Alcoholic Fatty Liver Disease and the Associated Brain Dysfunction,” Journal of Hepatology 78, no. 1 (2023): 180-190.

[212] K. Fischer, P. Hoffmann, S. Voelkl, et al., “Inhibitory Effect of Tumor Cell-Derived Lactic Acid on Human T Cells,” Blood 109, no. 9 (2007): 3812-3819.

[213] C. Chen, Y. Zhou, X. Ning, et al., “Directly Targeting ASC by Lonidamine Alleviates Inflammasome-Driven Diseases,” Journal of Neuroinflammation 19, no. 1 (2022): 315.

[214] Q. Lei, D. Wang, K. Sun, L. Wang, and Y. Zhang, “Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors,” Frontiers in Cell and Developmental Biology 8 (2020): 672.

[215] E. A. Ansa-Addo, Y. Zhang, Y. Yang, et al., “Membrane-Organizing Protein Moesin Controls Treg Differentiation and Antitumor Immunity via TGF-β Signaling,” Journal of Clinical Investigation 127, no. 4 (2017): 1321-1337.

[216] Y. S. Weng, H. Y. Tseng, Y. A. Chen, et al., “MCT-1/miR-34a/IL-6/IL-6R Signaling Axis Promotes EMT Progression, Cancer Stemness and M2 Macrophage Polarization in Triple-Negative Breast Cancer,” Molecular Cancer 18, no. 1 (2019): 42.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.